Market Value210,246,000
Total Holdings47
File Date2020-11-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ALDX / Aldeyra Therapeutics, Inc.
UTHR / United Therapeutics Corporation
US0906721065 / BioTelemetry, Inc.
ADMA / ADMA Biologics, Inc.
ESTA / Establishment Labs Holdings Inc.
LHCG / LHC Group Inc
ZGNX / Zogenix Inc Put
KRTX / Karuna Therapeutics, Inc.
TBIO / Telesis Bio, Inc.
CHNG / Change Healthcare Inc
AMRX / Amneal Pharmaceuticals, Inc.
BMYMP / Bristol-Myers Squibb Company - Preferred Security Call
AMN / AMN Healthcare Services, Inc.
US7438151026 / Providence Service Corp. (The)
US85789A1051 / STEALTH BIOTHERAPEUTICS CORP ADR
IMTX / Immatics N.V.
RETA / Reata Pharmaceuticals Inc - Class A
RETA / Reata Pharmaceuticals Inc - Class A Call
XERS / Xeris Biopharma Holdings, Inc.
NLTX / Neoleukin Therapeutics, Inc.
MGLN / Magellan Health Inc
BTAI / BioXcel Therapeutics, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
ACIU / AC Immune SA
ARWR / Arrowhead Pharmaceuticals, Inc.
EVFM / Evofem Biosciences, Inc.
CI / The Cigna Group
CBIO / Crescent Biopharma, Inc.
BMY / Bristol-Myers Squibb Company
EHC / Encompass Health Corporation
EOLS / Evolus, Inc. Call
MGTA / Magenta Therapeutics Inc
US0153511094 / Alexion Pharmaceuticals, Inc. Call
APTO / Aptose Biosciences Inc.
ONEM / 1life Healthcare Inc
AUPH / Aurinia Pharmaceuticals Inc.
KZR / Kezar Life Sciences, Inc.
MTCR / Metacrine Inc
VCEL / Vericel Corporation
CARA / Cara Therapeutics, Inc.
ARNA / Arena Pharmaceuticals Inc
QURE / uniQure N.V.
ZGNX / Zogenix Inc
APEN / Apollo Endosurgery Inc
BAX / Baxter International Inc.
TPTX / Turning Point Therapeutics Inc
EOLS / Evolus, Inc.
ONEM / 1life Healthcare Inc Put
NEO / NeoGenomics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
PSNL / Personalis, Inc.
ORGO / Organogenesis Holdings Inc.
QDEL / QuidelOrtho Corporation
ALBO / Albireo Pharma Inc
CUE / Cue Biopharma, Inc.
KIDS / OrthoPediatrics Corp.
PCRX / Pacira BioSciences, Inc.
OEF / iShares Trust - iShares S&P 100 ETF Put
ZBH / Zimmer Biomet Holdings, Inc.
KURA / Kura Oncology, Inc.
CNC / Centene Corporation
IMVT / Immunovant, Inc.
PRTA / Prothena Corporation plc
MGTX / MeiraGTx Holdings plc